2022 Universal Registration Document

Chapter 6 : Parent company financial statements

NOTE 15. Marketable securities

This item breaks down as follows:

€ millions 31.12.2022 31.12.2021 31.12.2020
Financial instruments/Premiums paid on options 76.8 33.4 63.9
Gross value 76.8 33.4 63.9
Financial instruments/Premiums paid on options - - -
Impairment - - -
NET VALUE 76.8 33.4 63.9

NOTE 16. Maturity of receivables

€ millions 1 year or less More than 1 year Gross Impairment Net
Loans and other receivables 219.8 3.4 223.2 -0.4 222.8
Other financial assets 4.7 - 4.7 -0.1 4.6
Trade accounts receivable 1,032.4 - 1,032.4 -1.5 1,030.9
Other current assets, of which 513.6 - 513.6 - 513.6
Tax and employee-related receivables(1) 431.3 - 431.3 - 431.3
Other receivables 82.3 - 82.3 - 82.3
Prepaid expenses 90.8 - 90.8 - 90.8

(1) Including a corporate income tax receivable in the amount of €86.2 million and a fine of €189.5 million paid to the French competition authority on 28 April 2015.

Accrual accounts included in receivables amounts are as follows:

€ millions 31.12.2022 31.12.2021 31.12.2020
Trade accounts receivable 3.0 2.0 1.2
Other receivables 20.5 23.1 19.1
TOTAL 23.5 25.1 20.3

NOTE 17. Stock purchase or subscription options – Free shares

17.1. Share subscription or purchase options

As at 31 December 2022, there were no more stock options plans in force.

17.2. Free shares

The table below summarises data relating to the free share plan.

Grant date Vesting date Number of shares granted Number of shares issued/allotted Number of shares not finally vested
Stock subscription plans Stock purchase plans
20.04.2016   21.04.2020 906,100 835,725 -
20.04.2017   21.04.2021 906,000 742,276 -
17.04.2018   18.04.2022 931,000 868,575 -
18.04.2019   19.04.2023 843,075 450 801,400
14.10.2020   15.10.2024 713,660 385 691,150
07.10.2021   08.10.2025 588,750 105 578,325
13.10.2022   14.10.2026 700,000 - 700,000

For the conditional grant of shares, the plan provides for a four-year vesting period after which vesting is effective and final, subject to meeting the conditions of the plan.

The performance conditions concern:

  • For the 7 October 2021, 14 October 2020 and 18 April 2019plans:
  • for 50% of shares granted, the comparable cosmetics net sales for the 2022, 2023 and 2024 financial years under the 2021 plan; for the 2021, 2022 and 2023 financial years under the 2020 plan; and the 2020, 2021 and 2022 financial years under the 2019 plan in relation to the growth in net sales for a panel of competitors;
  • for 50% of shares granted, the increase over the same period in the Group’s consolidated operating profit.